Morning Overview on MSN
Capivasertib won FDA approval for a hard-to-treat form of prostate cancer
Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time.
A Brisbane father is urging Queenslanders to remove the stigma around getting your prostate checked after early detection ...
MedPage Today on MSN
Recent Developments in Prostate Cancer
Practice-changing perioperative therapy, chemo-free combo for CSPC, reducing cognitive eff ...
Black men are much more likely to die from prostate cancer than the general population. A group of Chicago-area researchers ...
Two major types of stress can wrap their tentacles around our lives. One, known as “eustress”, is a positive cognitive response to short-term stress. This can motivate us to manage challenges and ...
Two larger doses of radiotherapy for prostate cancer cause no additional side effects compared to the standard five doses of radiotherapy, according to results presented at the Congress of ...
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is building a clinical case for Aquablation that could redefine its addressable ...
Novartis already received FDA approval of ITVISMA as a gene therapy for the treatment of patients with SMA. Read why NVS ...
New science-driven supplements and topical formulas expand Sisel's wellness portfolio with targeted support for testosterone levels, prostate health, and hormonal balance across every stage of life.
Not because intimacy had stopped mattering to them. But because nobody – not their GP, not their specialist, not the health ...
Experts explain why the hormone may be a meaningful signal for men’s overall health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results